Core Viewpoint -滨化集团股份有限公司 (滨化股份) is pursuing an IPO on the Hong Kong Stock Exchange, revealing a growth in revenue for 2024 but a decline in profits during the same period, alongside a significant increase in its debt-to-asset ratio, which reached 90.8% by mid-2025 [2][6]. Financial Performance - The revenue figures for滨化股份 from 2022 to 2024 are as follows: RMB 88.92 billion in 2022, RMB 73.06 billion in 2023, RMB 102.28 billion in 2024, and RMB 73.54 billion for the first half of 2025. However, profits decreased from RMB 12.03 billion in 2022 to RMB 2.17 billion in 2024 and further to RMB 1.36 billion in the first half of 2025 [3][4]. - The gross profit margin has significantly declined from 26.5% in 2022 to 6.4% in 2024, with net profit margins also dropping from 13.5% to 2.1% during the same period [7]. Debt and Inventory Management - The debt level of滨化股份 has rapidly increased, with the debt-to-asset ratio rising from 41.9% in 2022 to 90.8% by June 2025 [6][7]. - The company's inventory and contract costs have surged from RMB 580 million in 2022 to RMB 1.072 billion by the end of 2024, marking an 84.8% increase [4][5]. Business Operations and Strategy -滨化股份 operates in three main segments: chlor-alkali chemicals, C3 and C4 chemicals, and wet electronic chemicals, maintaining a leading position in the chlor-alkali chemicals sector and achieving rapid growth in the petrochemical and electronic chemicals fields [3]. - The company plans to utilize the funds raised from the IPO for various projects, including the construction of a source-network-load-storage project, enhancing R&D capabilities, and expanding its overseas sales and service network [7].

Group 1: Company Performance and Strategy - The company aims to continuously improve operational efficiency and profitability to enhance investment value and shareholder returns [2] - Over 70% of the company's products are exported, with a low proportion sold to the U.S. market [4] - The company is actively seeking business opportunities in Brazil, a key market for agricultural protection [3] Group 2: Product Development and Market Expansion - The company is working on launching the new pesticide, Cyhalofop-butyl, which requires domestic registration [3] - Plans to diversify into low-carbon chemical products and fluorinated new materials are underway [3] - The company is monitoring trade policy changes to adapt its strategies and maintain market competitiveness [4] Group 3: Financial Concerns and Market Reactions - The company acknowledges that stock price fluctuations are influenced by macroeconomic conditions and market trends [5] - As of the end of 2024, the company has unsold resources amounting to 120 billion yuan, with a high debt ratio of 85% [6] - The company emphasizes that it does not plan to sell core assets or equity as part of its debt restructuring efforts [6]

Core Insights - The agricultural chemical industry is undergoing a significant transformation from "quantity" to "quality" driven by global food security demands and modernization processes [2] - Taihe Co., Ltd. is positioned as a leader in the domestic market and is showcasing China's manufacturing capabilities on the international stage [2] - The company is transitioning from imitation to innovation, emphasizing its strategic management and operational execution to build a competitive moat [2] Industry Overview - The global agricultural pesticide market reached $74.8 billion in 2023, with a compound annual growth rate (CAGR) of 5.74% over the past five years [9] - The demand for pesticides is driven by global population growth and limited arable land, with herbicides, fungicides, and insecticides accounting for 47.2%, 24.96%, and 24.97% of the market, respectively [9] - The Asia-Pacific region and Latin America are the largest markets for pesticides, with sales of $25.08 billion and $22.07 billion in 2022, respectively [9] Company Positioning - Taihe Co., Ltd. focuses on the research, production, and sales of pesticide products and functional chemicals, with a strong emphasis on meeting international market demands since its establishment in 2004 [4] - The company has achieved significant revenue from its core products, with fungicides generating ¥1.187 billion (31.07% of total revenue) and herbicides generating ¥1.879 billion (49.18% of total revenue) in 2023 [4] - Taihe Co., Ltd. has established a robust research and development (R&D) system, with 363 patents (73 overseas) and participation in national key research plans [6] Technological Advancements - The company has developed a systematic technological advantage in key synthesis techniques, significantly reducing production costs and enhancing environmental performance [6][7] - Taihe Co., Ltd. has established long-term partnerships with international agricultural giants, ranking 6th in domestic pesticide exports in 2023 [8] - The company has expanded its product offerings in functional chemicals, increasing their share from 4.07% in 2021 to 14.07% in the first half of 2024 [5] Strategic Development - Taihe Co., Ltd. is transitioning from imitation to innovation by establishing a dedicated team for new pesticide creation and investing in the development of new compounds [11][12] - The company has successfully navigated the entire product development process, leading to the successful registration of new products, including the self-created compound that received export registration in July 2024 [13] - The company aims to leverage its technological capabilities and market insights to capture opportunities in high-potential overseas markets [9][10]

Core Viewpoint - Nantong Taihe Chemical Co., Ltd. (Taihe Co.) has successfully listed on the Shenzhen Stock Exchange's Growth Enterprise Market, with an issue price of 10.27 yuan per share and an opening price of 45.00 yuan per share, highlighting its strong market position and growth potential in the agricultural chemical sector [1] Group 1: Company Overview - Taihe Co. has over 20 years of experience in the agricultural chemical industry, establishing itself as a leader with core products such as Bacillus subtilis, Pyraclostrobin, and 2,4-D, dominating both production scale and technical capabilities [1][2] - The company has developed a complete industrial chain around its three core products, with subsidiaries leading in global production of Bacillus subtilis and 2,4-D, while maintaining a leading position in Pyraclostrobin production in China [2] Group 2: Innovation and Technology - Continuous investment in technology research and development has led to significant achievements, with Taihe Co. holding 363 patents as of June 30, 2024, including 73 overseas invention patents [3] - The company has introduced innovative products such as the new pesticide Cyhalofop-butyl and has established a comprehensive patent protection network, indicating strong future market potential [6] Group 3: Market Position and Strategy - Taihe Co. has been recognized as one of the top 25 companies in the agricultural chemical industry for four consecutive years, reflecting its strong market presence and competitive edge [5] - The company is strategically positioned within the global supply chain, collaborating with international giants like Syngenta and Dow, while focusing on original drug research and formulation sales [5] Group 4: Future Growth and Internationalization - The company aims to expand its business boundaries by transitioning from single product innovation to a product matrix innovation strategy, enhancing its market competitiveness [4][7] - Taihe Co. is committed to internationalization, adapting to global agricultural chemical trends and accelerating its international expansion to ensure sustainable business development [8]

Core Viewpoint - The listing of Taihe Co., Ltd. (301665.SZ) on the ChiNext board marks a significant event, as the company is a leader in the pesticide and functional chemicals industry, with a strong position in key products such as Bacillus subtilis, pyraclostrobin, and 2,4-D [1][2]. Group 1: Company Overview - Taihe Co., Ltd. specializes in the research, production, and sales of pesticide products and functional chemicals, holding a leading position in the industry in terms of production scale and comprehensive technology level [1]. - The company has established long-term strategic partnerships with multinational corporations such as Syngenta, Dow, and Honeywell, expanding its market reach to regions including South America, North America, Southeast Asia, and Europe [3]. Group 2: Financial Metrics - The initial public offering (IPO) price was set at 10.27 CNY per share, with an institutional offering price of 10.68 CNY per share, resulting in a market capitalization of 46.22 billion CNY [2]. - The company’s earnings report indicates a significant growth trajectory, with a projected revenue increase of 60% [2]. - The company’s issuance price corresponds to a price-to-earnings (P/E) ratio of 13.40, compared to the industry average P/E ratio of 23.01 [2]. Group 3: Fund Utilization - The company plans to allocate 8.96 billion CNY (85.76%) of the raised funds towards a fungicide project and 1.49 billion CNY (14.24%) towards a research and development center project [2]. Group 4: Export Performance - From 2021 to 2024, the company’s overseas sales revenue was 28.01 billion CNY, 45.49 billion CNY, 29.46 billion CNY, and 14.54 billion CNY, representing 78.42%, 89.58%, 77.10%, and 74.43% of total operating income, respectively [3].

Core Insights - The chairman of Taihe Co., Tian Xiaohong, emphasizes the importance of the pesticide industry for food security and agricultural productivity, highlighting the need for safe and environmentally friendly agricultural chemicals [2][3][4] - Taihe Co. has transitioned from merely trading pesticides to integrating research, production, and technology, aiming to innovate and compete with global agricultural giants [3][4] - The company has developed key products such as Bacillus amyloliquefaciens, 2,4-D, and pyraclostrobin, which are significant in the global market, with Bacillus amyloliquefaciens holding a 60% market share [6][7] Industry Context - The global population growth poses challenges for food security, with the need for increased agricultural productivity being critical, where pesticides play a vital role [3][4] - China produces 70% to 80% of the world's pesticides but still lags behind major global players in high-end agricultural products [3][4] - The pesticide industry is currently facing overcapacity and a "micro-profit era," prompting companies like Taihe to innovate and adapt to maintain competitiveness [8] Company Strategy - Taihe Co. has focused on R&D, with over 3% of its revenue allocated to innovation since 2021, resulting in 363 patents, including 73 overseas [8][9] - The company plans to use funds from its IPO to enhance its core product line of fungicides and develop a complete product line [8][9] - Future investments will target the construction of new production capacities for green pesticides, aligning with international agricultural trends [9][10]